PDS Biotechnology PDSB
NASDAQ PDSB
$0.22 +0.01 (+4.60%)
At close: Aug 21, 2026 · 4:00 PM EDT

PDS Biotechnology (PDSB) Amortizatization of Intangibles (2014 - 2026)

PDS Biotechnology's (PDSB) quarterly Amortizatization of Intangibles came in at $474408.0 in Q4 2025, down 57.94% YoY from $1.1 million in Q4 2024, and up 476.23% on a QoQ basis from $82329.0 in Q2 2025.

PDS Biotechnology (PDSB) Amortizatization of Intangibles (2014 - 2026) Analysis & Trends

PDS Biotechnology (PDSB) has 9 years of Amortizatization of Intangibles data on file, last reported at $474408.0 in Q4 2025.

  • Quarterly Amortizatization of Intangibles fell 57.94% year-over-year to $474408.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $566407.0 (down 67.19% YoY) and the FY2025 annual result came in at $1.6 million, up 34.31% from the prior year.
  • Amortizatization of Intangibles improved to $474408.0 in Q4 2025, from $82329.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $1.1 million in Q4 2024 to a low of -$351953.0 in Q4 2023.
  • A 4-year average of $185860.2 and a median of $111192.0 in 2022 frame the typical range for Amortizatization of Intangibles.
  • Annual changes were most pronounced in 2023 — Amortizatization of Intangibles tumbled 416.53% — and 2024, when it soared 420.47%.
  • Tracing PDSB's Amortizatization of Intangibles over 4 years: stood at $111192.0 in 2022, then plunged by 416.53% to -$351953.0 in 2023, then soared by 420.47% to $1.1 million in 2024, then sank by 57.94% to $474408.0 in 2025.
  • The last three Amortizatization of Intangibles figures came in at $474408.0 (Q4 2025), $82329.0 (Q2 2025), and $9670.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 PDS Biotechnology 12.02 Mn 12.02 Mn - 265,549.00

Historic Data

Download Data
DateValue
Jun 30, 2026 265,549.00
Jun 30, 2026 265,549.00
Dec 31, 2025 474,408.00
Dec 31, 2025 474,408.00
Jun 30, 2025 82,329.00
Jun 30, 2025 82,329.00
Mar 31, 2025 9,670.00
Mar 31, 2025 9,670.00
Dec 31, 2024 1.13 Mn
Dec 31, 2024 1.13 Mn
Sep 30, 2024 305,125.00
Sep 30, 2024 305,125.00
Jun 30, 2024 283,774.00
Jun 30, 2024 283,774.00
Mar 31, 2024 9,670.00
Mar 31, 2024 9,670.00
Dec 31, 2023 -351,953.00
Dec 31, 2023 -351,953.00
Sep 30, 2023 158,397.00
Sep 30, 2023 158,397.00